Literature DB >> 23182123

[Utero-vaginal suspension using a bilateral vaginal anterior sacrospinous fixation with mesh. Preliminary results].

G Rivaux1, B Fatton, V Letouzey, M Cayrac, L Boileau, R de Tayrac.   

Abstract

OBJECTIVE: To assess anatomical and functional preliminary results, and safety of a new surgical approach for a combined treatment of pelvic organ prolapse (POP) of anterior and medium compartments, using a mesh attached through the sacrospinous ligaments with the UpHold(®) system (Boston Scientific) and the Capio(®).
MATERIAL AND METHODS: A longitudinal case series of 59 consecutive patients operated between October 2009 and January 2012, by five senior surgeons in a single tertiary unit.
RESULTS: Mean age was 66.9 years. Ten patients (17%) had previous pelvic organ prolapse (POP) surgery. There was no intraoperative complication. Mean follow-up was 12 months. Anatomical success for both anterior and apical compartments, i.e. Ba and C/D point<1, was 93% (52/56). Anatomical results shown correction of cystocele with a mean Ba point from+0.79 cm (range -3 to +8) to -2.35 cm (range -3 to 0), correction of uterine/vaul prolapse with a mean C/D point from+0.14 cm (range -6 to+8) to -7.29 cm (range -9 to -1), and correction of rectocele with a mean Bp point from -0.68 cm (range -3 to 7) to -2.77 cm (range -3 to -1). Two patients required further surgery for mesh exposure (3.5%). One patient had a unilateral pudendal neuropathic pain postoperatively.
CONCLUSION: In the current series, utero-vaginal suspension using a bilateral vaginal anterior sacrospinous fixation with mesh was associated with good anatomical success rates. Prospective, comparative and long-term data are needed.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23182123     DOI: 10.1016/j.purol.2012.10.005

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  7 in total

1.  Transvaginal repair of stage III-IV cystocele using a lightweight mesh: safety and 36-month outcome.

Authors:  Renaud de Tayrac; Majid Brouziyne; Gérard Priou; Guy Devoldère; Gérard Marie; Joël Renaudie
Journal:  Int Urogynecol J       Date:  2015-03-03       Impact factor: 2.894

2.  Utero-vaginal suspension using bilateral vaginal anterior sacrospinous fixation with mesh: intermediate results of a cohort study.

Authors:  Vincent Letouzey; Daniela Ulrich; Eva Balenbois; Arnaud Cornille; Renaud de Tayrac; Brigitte Fatton
Journal:  Int Urogynecol J       Date:  2015-05-31       Impact factor: 2.894

3.  High risk of complications with a single incision pelvic floor repair kit: results of a retrospective case series.

Authors:  Stephen T Jeffery; Kendall Brouard
Journal:  Int Urogynecol J       Date:  2013-07-02       Impact factor: 2.894

4.  Anterior-apical single-incision mesh surgery (uphold): 1-year outcomes on lower urinary tract symptoms, anatomy and ultrasonography.

Authors:  Tsia-Shu Lo; Leng Boi Pue; Yiap Loong Tan; Wu-Chiao Hsieh; Chuan Chi Kao; Ma Clarissa Uy-Patrimonio
Journal:  Int Urogynecol J       Date:  2018-07-14       Impact factor: 2.894

5.  Prophylactic midurethral sling insertion during transvaginal pelvic reconstructive surgery for advanced prolapse patients with high-risk predictors of postoperative de novo stress urinary incontinence.

Authors:  Tsia-Shu Lo; Sandy Chua; Chuan Chi Kao; Wu-Chiao Hsieh; Ming-Ping Wu; Ling-Hong Tseng
Journal:  Int Urogynecol J       Date:  2018-10-18       Impact factor: 2.894

6.  1-year outcome after treatment of uterovaginal prolapse with a 6-point fixation mesh.

Authors:  Andreas Brandt; Andrzej Kuszka; Achim Niesel; Henrik Lutz; Christian Fünfgeld; Mathias Mengel; Daniela Ulrich
Journal:  Neurourol Urodyn       Date:  2019-03-14       Impact factor: 2.696

7.  Genital prolapse: epidemiology, clinic and therapeutic at Saint Joseph Hospital of Kinshasa.

Authors:  Antoine Tshimbundu Kayembe; Andy Mbangama Muela; Alex Mutombo Baleka; Dieudonné Sengeyi Mushengezi; Rahma Rachid Tozin
Journal:  Pan Afr Med J       Date:  2020-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.